Non-Hodgkins lymphoma of bilateral eyelids with basal cell carcinoma of nose: a rare case report

Dorafiona Swer; Rahul Mahawar; Yumkhaibam Sobita Devi; Dangtila Sangtam

doi:10.18203/2320-6012.ijrms20241931

Authors

Dorafiona Swer Department of Radiation Oncology, Regional Institute of Medical Sciences, Imphal, Manipur, India
Rahul Mahawar Department of Radiation Oncology, Regional Institute of Medical Sciences, Imphal, Manipur, India
Yumkhaibam Sobita Devi Department of Radiation Oncology, Regional Institute of Medical Sciences, Imphal, Manipur, India
Dangtila Sangtam Department of Radiation Oncology, Regional Institute of Medical Sciences, Imphal, Manipur, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20241931

Keywords:

Non-Hodgkin lymphoma, Basal cell carcinoma, Eyelids, Skin, Nose

Abstract

Malignant tumours affecting the eyelid mainly include basal cell carcinoma. Non-Hodgkin’s lymphoma may occur in almost any part of the body and should be considered in the differential diagnosis of extra lymphoid tumours. Non- Hodgkin’s lymphoma of the eyelid is rare. Rare diseases should be considered in differential diagnoses because they have the tendency for rapid systemic involvement and they may require treatments that are different from the other common diseases. Basal cell carcinoma occurs most frequently at sun-exposed sites, most commonly in the head and neck regions. The aim of any therapy selected for BCC treatment involving the head and neck is to ensure complete removal, functional preservation, and a good cosmetic outcome. Here, we reported a case of a 70-year-old female with non-Hodgkin lymphoma of eyelids followed by basal cell carcinoma of the nose treated with multimodality approach.

Metrics

Metrics Loading ...

References

Lymphoma Information Network. Lymphoma of the eyelid. Available at: http://www.lymphomainfo.net/nhl/types/eyelid.html Accessed on 21 April 2011.

Bairey O, Kremer I, Rakowsky E, Hadar H, Shaklai M. Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma. Cancer. 1994;73:2395-9.

Moslehi R, Coles FB, Schymura MJ. Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin's lymphoma. Expert Rev Ophthalmol. 2011;6:175-80.

Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer. 1993;53(4):585-90.

Wollina U, Bennewitz A, Langner D. Basal cell carcinoma of the outer nose: overview on surgical techniques and analysis of 312 patients. J Cutan Aesthet Surg. 2014;7:143-50.

Tifikcioglu YO, Karaaslan O, Aksoy HM, Aksoy B, Kocer U. Basal cell carcinoma in Turkey. J Dermatol. 2006;33(2):91-5.

Sarah EC, Krause L, Delecluse HJ. Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases. Ophthalmology. 1998;105:1430-41.

Ferry JA, Fung CY, Zukerberg L. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol. 2007;31:170-84.

Baldini L, Blini M, Guffanti A. Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Ann Oncol. 1998;9:779-81.

Rosado MF, Byme GE, Ding F. Ocular adnexal lymphoma: a cliniopathological study of a large cohort of patients with no evidence for an association with chlamydia psittaci. Blood. 2006;107:467-72.

Delishaj D, Rembielak A, Manfredi B. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: A review of literature. J Contemp Brachytherapy. 2016;8:533-40.

Ballester-Sánchez R, Pons-Llanas O, Candela-Juan C. Electronic brachytherapy for superficial and nodular basal cell carcinoma: A report of two prospective pilot trials using different doses. J Contemp Brachyther. 2016;8:48-55.